UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2012		Sep. 30, 2011
Operating activities
Net income	$ 11,387		$ 5,630
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	3,258		2,969
Provision for loan and lease losses	15,047		16,654
Net amortization of investment securities discounts/premiums	1,360		483
Stock-based compensation expense	1,872		1,276
Mortgage loans originated for sale	(233)		(458)
Sale of mortgage loans originated for resale	237		462
Gain on sale of mortgage loans originated for resale	(4)		(4)
Net change in commercial loans held for sale	(7,970)		0
Deferred income tax expense	2		0
Gain on sales of fixed assets	(29)		(26)
Other than temporary impairment on securities held-to-maturity	126	[1]	75	[1]
Losses on sale and writedowns on other real estate owned	2,405		555
Gain on sales of investment securities	(107)		(623)
(Increase) decrease in accrued interest receivable	(1,585)		337
Decrease in interest payable	(23)		(11)
Increase in other assets	(4,693)		(335)
Increase in other liabilities	711		3,450
Net cash provided by operating activities	21,761		30,434
Investing activities
Purchase of investment securities available-for-sale	(282,669)		(283,914)
Proceeds from call of securities held-to-maturity	0		4,000
Proceeds from sale of investment securities available-for-sale	6,297		23,846
Proceeds from redemptions and repayment of securities available-for-sale	90,951		81,680
Proceeds from sale of other real estate owned	5,157		894
Net (increase) decrease in loans	(126,930)		(115,248)
Proceeds from sale of fixed assets	171		68
Purchases of premises and equipment	(3,599)		(1,390)
Net cash used in investing activities	(310,622)		(290,064)
Financing activities
Net increase in deposits	98,624		1,049,404
Net (decrease) increase in securities sold under agreements to repurchase	(14,375)		10,674
Repayment of short-term borrowings and federal funds purchased	0		(136,000)
Proceeds from issuance of common stock	0		54,501
Proceeds from the exercise of options	98		0
Excess tax benefit from share-based payment arrangements	(2)		0
Net cash provided by financing activities	84,345		978,579
Net (decrease) increase in cash and cash equivalents	(204,516)		718,949
Cash and cash equivalents, beginning of period	749,174		472,319
Cash and cash equivalents, end of period	544,658		1,191,268
Supplemental disclosure:
Interest paid	8,854		9,072
Taxes paid	8,367		5,132
Transfers of loans to other real estate owned	$ 3,222		$ 5,749

[1] Other than temporary impairment was due to credit loss and therefore did not include amounts due to market conditions.